Average Co-Inventor Count = 6.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Usher III Initiative, Inc. (9 from 9 patents)
2. Astrazeneca Ab (1,500 patents)
9 patents:
1. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
2. 9925187 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
3. 9783545 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
4. 9549910 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
5. 9371332 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome
6. 9260381 - Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome
7. 9227976 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
8. 9079909 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
9. 8765762 - Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome